If it is found effective and if approved by the FDA, the vaccine would protect anyone over 5 years old.
. "Lyme disease continues to spread, representing a high unmet medical need that impacts the lives of many in the Northern Hemisphere."
, but claims of adverse side effects like arthritis — which the FDA said were unfounded — and a low-ish 75% rate of effectiveness, led its manufacturer to discontinue the drug. At the same time, 20 years ago Lyme was not as widespread as it is now and the medical world was not as aware of its long-term effects.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer just started a late-stage clinical trial of a Lyme disease vaccineIf the trial succeeds, the vaccine could be the first human immunization for Lyme disease in the U.S. in two decades.
Weiterlesen »
Clinical trial aims to develop 1st Lyme disease vaccine in 20 yearsThe Centers for Disease Control (CDC) said the only other Lyme disease vaccine in the U.S. was discontinued in 2002 because of low consumer demand.
Weiterlesen »
Major test of 1st possible Lyme disease vaccine in 20 years beginsWhat is Lyme disease? Black-legged ticks, also called deer ticks, carry Lyme-causing bacteria. The infection initially causes fatigue, fever and joint pain.
Weiterlesen »
Pfizer Begins Trial for Lyme Disease VaccineIf the trial succeeds, the vaccine could be the first human vaccine for the tick-borne illness in the US in two decades.
Weiterlesen »
What the Lyme disease vaccine could mean for people with long-term symptomsNow entering late-stage clinical trials, the vaccine could be approved as soon as 2025.
Weiterlesen »
Major test of first possible Lyme vaccine in 20 years beginsResearchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years
Weiterlesen »